BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9755121)

  • 1. Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis.
    Bischoff A; Rascher W; Michel MC
    Am J Physiol; 1998 Oct; 275(4):F502-9. PubMed ID: 9755121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction.
    Bischoff A; Erdbrügger W; Smits J; Michel MC
    J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):525-34. PubMed ID: 8887762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is bradykinin a mediator of renal neuropeptide Y effects?
    Bischoff A; Neumann A; Dendorfer A; Michel MC
    Pflugers Arch; 1999 Nov; 438(6):797-803. PubMed ID: 10591068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion.
    Bischoff A; Michel MC
    Can J Physiol Pharmacol; 2000 Feb; 78(2):93-9. PubMed ID: 10737671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats.
    Bischoff A; Limmroth V; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):704-8. PubMed ID: 9694924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of neuropeptide Y.
    Bischoff A; Michel MC
    Pflugers Arch; 1998 Mar; 435(4):443-53. PubMed ID: 9446690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats.
    Bischoff A; Meyer Zu Heringdorf D; Jakobs KH; Michel MC
    Br J Pharmacol; 2001 Apr; 132(8):1925-33. PubMed ID: 11309265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats.
    Mansoori A; Oryan S; Nematbakhsh M
    J Physiol Pharmacol; 2014 Oct; 65(5):633-9. PubMed ID: 25371522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
    Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):194-200. PubMed ID: 7477443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats.
    Sakamoto T; Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):84-9. PubMed ID: 7935859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine.
    Czyborra C; Bischoff A; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):37-44. PubMed ID: 16521006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of icatibant on the ramipril-induced decreased in renal lithium clearance in the rat.
    Bagaté K; Grima M; De Jong W; Imbs JL; Barthelmebs M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):281-7. PubMed ID: 11284442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis.
    Madrid MI; García-Salom M; Tornel J; De Gasparo M; Fenoy FJ
    Am J Physiol; 1997 Nov; 273(5):R1676-82. PubMed ID: 9374809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
    Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
    Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Nifedipine on Renal and Cardiovascular Responses to Neuropeptide Y in Anesthetized Rats.
    Bischoff A; Stickan-Verfürth M; Michel MC
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.